Please enter the email address you used to register, then we will send you a link to choose a new password
TD Cowen analyst Dan Brennan maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $14 to $24.
BTIG analyst Mark Massaro maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $15 to $19.
GeneDx Hldgs (NASDAQ: WGS) raises FY2024 sales outlook from $220.00 million-230.00 million to $235.00 million-245.00 million.Ge...
GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%...
GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.67) b...
BTIG analyst Mark Massaro maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $11 to $15.
Goldman Sachs analyst Matthew Sykes maintains GeneDx Hldgs (NASDAQ:WGS) with a Neutral and raises the price target from $6 t...
Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company r...
GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific c...